Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Future considerations for the mRNA-lipid nanoparticle vaccine platform

24 Apr 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33906124
DOI: 10.1016/j.coviro.2021.03.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Future considerations for the mRNA-lipid nanoparticle vaccine platformPMID 33906124Read ↗

Lipid nanoparticles in the development of mRNA vaccines for COVID-19Semantic proximity Read ↗

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read ↗

Engineering of mRNA vaccine platform with reduced lipids and enhanced efficacySemantic proximity Read ↗

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based TherapeuticsSemantic proximity Read ↗

The Delivery of mRNA Vaccines for TherapeuticsSemantic proximity Read ↗

Formulation and Evaluation of Bivalent Swine and Avian Lipid Nanoparticles mRNA VaccineSemantic proximity Read ↗

Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunitySemantic proximity Read ↗

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read ↗

Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic VirusesSemantic proximity Read ↗

Recent Advances in mRNA Vaccine DevelopmentSemantic proximity Read ↗

An Update on mRNA-Based Viral VaccinesSemantic proximity Read ↗

From structural design to delivery: mRNA therapeutics for cancer immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.